Your browser doesn't support javascript.
loading
Levosimendan as a treatment for acute renal failure associated with cardiogenic shock after hip fracture / Levosimendana como tratamento para insuficiência renal aguda associada a choque cardiogênico após fratura de quadril
Hinojosa, Fabiola Quinteros; Revelo, Margarita; Salazar, Alexander; Maggi, Genaro; Schiraldi, Renato; Brogly, Nicolas; Gilsanz, Fernando.
  • Hinojosa, Fabiola Quinteros; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
  • Revelo, Margarita; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
  • Salazar, Alexander; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
  • Maggi, Genaro; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
  • Schiraldi, Renato; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
  • Brogly, Nicolas; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
  • Gilsanz, Fernando; Hospital Universitario de La Paz. Servicio de Anestesiologia. Madrid. ES
Rev. bras. anestesiol ; 67(1): 89-91, Jan.-Feb. 2017.
Article in English | LILACS | ID: biblio-843348
ABSTRACT
Abstract Inotropic drugs are part of the treatment of heart failure; however, inotropic treatment has been largely debated due to the increased incidence of adverse effects and increased mortality. Recently levosimendan, an inotropic positive agent, has been proved to be effective in acute heart failure, reducing the mortality and improving cardiac and renal performance. We report the case of a 75-year-old woman with history of heart and renal failure and hip fracture. Levosimendan was used in preoperative preparation as an adjuvant therapy, to improve cardiac and renal function and to allow surgery.
RESUMO
Resumo Fármacos inotrópicos fazem parte do tratamento de insuficiência cardíaca; no entanto, o tratamento com inotrópicos tem sido amplamente debatido devido ao aumento da incidência de efeitos adversos e da mortalidade. Recentemente, levosimendana, um agente inotrópico positivo, provou ser eficaz na insuficiência cardíaca aguda, reduz a mortalidade e melhora o desempenho cardíaco e renal. Relatamos o caso de uma paciente de 75 anos, com história de insuficiência cardíaca e renal e fratura de quadril. Levosimendana foi usada na preparação do pré-operatório como terapia adjuvante para melhorar a função cardíaca e renal e permitir a cirurgia.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Pyridazines / Shock, Cardiogenic / Vasodilator Agents / Cardiotonic Agents / Acute Kidney Injury / Hip Fractures / Hydrazones Type of study: Etiology study / Risk factors Limits: Aged / Female / Humans Language: English Journal: Rev. bras. anestesiol Journal subject: Anesthesiology Year: 2017 Type: Article Affiliation country: Spain Institution/Affiliation country: Hospital Universitario de La Paz/ES

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Pyridazines / Shock, Cardiogenic / Vasodilator Agents / Cardiotonic Agents / Acute Kidney Injury / Hip Fractures / Hydrazones Type of study: Etiology study / Risk factors Limits: Aged / Female / Humans Language: English Journal: Rev. bras. anestesiol Journal subject: Anesthesiology Year: 2017 Type: Article Affiliation country: Spain Institution/Affiliation country: Hospital Universitario de La Paz/ES